| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.STR.0000155686.73908.3E |
| P698 | PubMed publication ID | 15692125 |
| P50 | author | Domenico Inzitari | Q114342895 |
| P2093 | author name string | Leonardo Pantoni | |
| Andrea G Soglian | |||
| Daniela Binelli | |||
| Giovanni Spadari | |||
| Silvia Amigoni | |||
| Teodoro del Ser | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dementia | Q83030 |
| placebo | Q269829 | ||
| vascular dementia | Q583908 | ||
| P304 | page(s) | 619-624 | |
| P577 | publication date | 2005-02-03 | |
| P1433 | published in | Stroke Journal | Q7624282 |
| P1476 | title | Efficacy and safety of nimodipine in subcortical vascular dementia: a randomized placebo-controlled trial | |
| P478 | volume | 36 |
| Q35184834 | Age-related white matter changes |
| Q37106942 | Alzheimer's and non-alzheimer's dementia: a critical review of pharmacological and nonpharmacological strategies |
| Q34583326 | Cerebral oxygenation and haemodynamic effects induced by nimodipine in healthy subjects. |
| Q28287345 | Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges |
| Q31155412 | Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology |
| Q37810697 | Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology |
| Q33699950 | NGF and TERT co-transfected BMSCs improve the restoration of cognitive impairment in vascular dementia rats |
| Q37330167 | Nicardipine: a hypotensive dihydropyridine-type calcium antagonist with a peculiar cerebrovascular profile |
| Q90327038 | Nimodipine Reappraised: An Old Drug With a Future |
| Q47939931 | Nimodipine activates neuroprotective signaling events and inactivates autophages in the VCID rat hippocampus |
| Q37330158 | Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies |
| Q33908544 | Nimodipine for primary degenerative, mixed and vascular dementia |
| Q101165866 | Nimodipine improves cortical efficiency during working memory in healthy subjects |
| Q30558416 | Nimodipine improves regional cerebral blood flow and suppresses inflammatory factors in the hippocampus of rats with vascular dementia |
| Q26798286 | Nimodipine in otolaryngology: from past evidence to clinical perspectives |
| Q36630797 | Nimodipine, a calcium channel blocker, delays the spontaneous LH surge in women with regular menstrual cycles: a prospective pilot study. |
| Q34403971 | Rationale and design of a double-blind, placebo-controlled, randomized trial to evaluate the safety and efficacy of nimodipine in preventing cognitive impairment in ischemic cerebrovascular events (NICE) |
| Q38239508 | Recent patents on calcium channel blockers: emphasis on CNS diseases. |
| Q37653889 | Recent updates on subcortical ischemic vascular dementia |
| Q22242395 | Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline |
| Q43006982 | S3 guidelines on dementia. Symptomatic therapy of dementia |
| Q33462283 | Subcortical ischemic cerebrovascular dementia |
| Q36156335 | Subcortical ischemic vascular dementia |
| Q35033101 | The evidence for treating hypertension in older people with dementia: a systematic review. |
| Q33517025 | The restoration after repetitive transcranial magnetic stimulation treatment on cognitive ability of vascular dementia rats and its impacts on synaptic plasticity in hippocampal CA1 area |
| Q48118846 | Treatment of Vascular Cognitive Impairment. |
| Q47128027 | Treatment of vascular dementia. Recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology |
| Q51769067 | Vascular cognitive impairment. |
Search more.